Abstract
OBJECTIVE:
Twenty-six cases of lithium-induced hyperparathyroidism have been reported in the literature. This article describes an additional case that illustrates current management recommendations.
DESIGN:
Case report. Clinical presentation and proposed mechanisms of the suspected drug-induced effect are discussed.
CONCLUSIONS:
Serum calcium concentrations should be determined before and periodically during long-term lithium carbonate therapy. Discontinuation of therapy in patients who develop lithium-induced parathyroid dysfunction generally corrects calcium and parathyroid hormone concentrations. Surgery is indicated in patients with complications of hyperparathyroidism.
Get full access to this article
View all access options for this article.
